Connor, Clark & Lunn Investment Management (CC&L)’s Insmed INSM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $22.8M | Buy |
226,142
+210,999
| +1,393% | +$21.2M | 0.08% | 222 |
|
2025
Q1 | $1.16M | Buy |
+15,143
| New | +$1.16M | 0.01% | 902 |
|
2024
Q3 | – | Sell |
-41,908
| Closed | -$2.81M | – | 1541 |
|
2024
Q2 | $2.81M | Sell |
41,908
-40,175
| -49% | -$2.69M | 0.01% | 566 |
|
2024
Q1 | $2.23M | Sell |
82,083
-189,229
| -70% | -$5.13M | 0.01% | 639 |
|
2023
Q4 | $8.41M | Sell |
271,312
-174,792
| -39% | -$5.42M | 0.04% | 309 |
|
2023
Q3 | $11.3M | Sell |
446,104
-39,355
| -8% | -$994K | 0.06% | 240 |
|
2023
Q2 | $10.2M | Sell |
485,459
-30,915
| -6% | -$652K | 0.05% | 252 |
|
2023
Q1 | $8.8M | Sell |
516,374
-9,905
| -2% | -$169K | 0.05% | 273 |
|
2022
Q4 | $10.5M | Buy |
526,279
+323,503
| +160% | +$6.46M | 0.06% | 224 |
|
2022
Q3 | $4.37M | Buy |
202,776
+154,711
| +322% | +$3.33M | 0.03% | 340 |
|
2022
Q2 | $948K | Buy |
48,065
+35,205
| +274% | +$694K | 0.01% | 639 |
|
2022
Q1 | $302K | Buy |
+12,860
| New | +$302K | ﹤0.01% | 872 |
|
2016
Q1 | – | Sell |
-50,100
| Closed | -$909K | – | 868 |
|
2015
Q4 | $909K | Sell |
50,100
-25,700
| -34% | -$466K | 0.01% | 459 |
|
2015
Q3 | $1.41M | Sell |
75,800
-13,900
| -15% | -$258K | 0.01% | 348 |
|
2015
Q2 | $2.19M | Sell |
89,700
-16,100
| -15% | -$393K | 0.02% | 226 |
|
2015
Q1 | $2.2M | Buy |
105,800
+34,500
| +48% | +$718K | 0.02% | 220 |
|
2014
Q4 | $1.1M | Buy |
+71,300
| New | +$1.1M | 0.01% | 296 |
|
2014
Q2 | – | Sell |
-28,200
| Closed | -$593K | – | 585 |
|
2014
Q1 | $593K | Buy |
+28,200
| New | +$593K | ﹤0.01% | 457 |
|
2013
Q4 | – | Sell |
-23,000
| Closed | -$369K | – | 740 |
|
2013
Q3 | $369K | Buy |
23,000
+8,700
| +61% | +$140K | ﹤0.01% | 404 |
|
2013
Q2 | $180K | Buy |
+14,300
| New | +$180K | ﹤0.01% | 478 |
|